United States · FDA National Drug Code directory
OLMESARTAN MEDOXOMIL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49252-066_f29310d1-7b00-4057-9dd1-d9a69f542d5e
- Product NDC
- 49252-066
- Form
- TABLET, COATED
- Composition / generic term
- olmesartan medoxomil
- Labeler
- Inventia Healthcare Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200529
- Source listing expiry
- 20261231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BOTTLE (49252-066-10) · 49252-066-10
- 90 TABLET, COATED in 1 BOTTLE (49252-066-12) · 49252-066-12
- 1000 TABLET, COATED in 1 BOTTLE (49252-066-18) · 49252-066-18
- 10 CARTON in 1 BLISTER PACK (49252-066-57) / 10 TABLET, COATED in 1 CARTON · 49252-066-57
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →